First Manhattan
KLDO

First Manhattan’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

First Manhattan’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed – – 1734
2022
Q1 		$0 Hold
100
– – ﹤0.01% 1748
2021
Q4 		$0 Hold
100
– – ﹤0.01% 1742
2021
Q3 		$0 Hold
100
– – ﹤0.01% 1728
2021
Q2 		$0 Hold
100
– – ﹤0.01% 1662
2021
Q1 		$0 Hold
100
– – ﹤0.01% 1594
2020
Q4 		$0 Hold
100
– – ﹤0.01% 1445
2020
Q3 		$1K Hold
100
– – ﹤0.01% 1307
2020
Q2 		$0 Hold
100
– – ﹤0.01% 1509
2020
Q1 		$0 Buy
+100
New +$653 ﹤0.01% 1493

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First Manhattan's KLDO Position: Q2 2022 in Review

First Manhattan sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 100 shares.

First Manhattan first reported a position in KLDO in Q1 2020 and held it in 9 quarters. The position peaked at $1K in Q3 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • First Manhattan reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • First Manhattan sold 100 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
  • First Manhattan first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • First Manhattan's Kaleido Biosciences, Inc. Common Stock position peaked at $1K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on First Manhattan's 13F filing for Q2 2022, filed 15 Aug 2022.